IDC FutureScape: Worldwide Life Sciences 2024 Predictions

IDC FutureScape Figure

• Figure: IDC FutureScape: Worldwide Life Sciences 2024 Top 10 Predictions

Executive Summary

IDC FutureScape Predictions

• Summary of External Drivers

• Predictions: Impact on Technology Buyers

• Prediction 1: By 2024, 70% of Life Sciences Organizations Will Prioritize Security-by-Design, Privacy-by-Design, and Zero Trust Initiatives to Enhance Cyber-Resilience and Build Trust, Fueled by Evolving Regulations

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 2: By 2025, Transformative Patient Experiences Will Be Led by 30% of Life Sciences Firms That Used GenAI to Optimize Trial Design, Hyper-Personalize Content, and Orchestrate Empathetic Interactions

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 3: By 2026, 65% of Life Sciences Companies Will Modernize Digital Infrastructure, Adopting Unified Control Planes to Optimize and Scale Intelligence-Driven Innovation and to Ensure Regulatory Compliance

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 4: Pushed by Data-Driven Market Models and Patient Care Needs, 40% of Life Sciences Companies Will Adopt Integrated Solutions Combining Connected Medical Devices and Digital Health Platforms by 2026

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 5: Fueled by Connected Health Devices and AI-Based Analysis Tools, the Market for Digital Biomarkers Will Double by the End of 2026, Lowering Healthcare Costs While Aiding in R&D and Outcome Measurements

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 6: By 2026, the Adoption of GenAI-Based Drug Design, the Intelligent Supply Chain for Cell and Gene Therapies, and Digital Therapeutics Will Scale the Growth of Precision Therapies by 60%

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 7: Despite the Decreasing Field Sales Head Count, GenAI Enhancements in Commercial Life Sciences Software Will Lead the Industry to a 40% Rise in Personalized Engagements with Healthcare Providers by 2027

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 8: Evolving Home Care Initiatives and Patient Expectations Will Triple the Use of Intelligent Device–Based Drug Delivery Systems by 2027, Followed by Vectorized Antibodies and Gene Delivery Nanocarriers

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 9: By 2027, One-Fourth of the Life Sciences Industry Will Supplement But Not Replace Animal Testing with Computer Simulations, Organoids, and Organ on a Chip, Prioritizing Neurological Diseases

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 10: Approvals for Clinical Trials Focused on a Brain-Computer Interface Will Double by 2028, Prioritizing Neurorehabilitation While Implementing Strict Guardrails to Ensure Data Privacy and Patient Safety

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

Advice for Technology Buyers

External Drivers: Detail

• AI Everywhere — Generative AI Takes the Spotlight

• The Drive to Automate — Maximizing Efficiency and New Opportunities

• Cybersecurity and Risk — Building Resilience Against Multiplying Threats

• The Digital Business Imperative — Competitiveness and Outcomes

• Dynamic Work and Skills Requirements — New Work Mode Era

• Shifting Tech Regulatory Landscape — Navigating Risk and Opportunity

Learn More

• Related Research